Related Experiment Videos
Polyarteritis nodosa--a few unusual findings
1Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh.
Indian Pediatrics
|June 1, 1996
Summary
This study on childhood polyarteritis nodosa (PAN) in North India found that treatment with prednisolone and cyclophosphamide improved outcomes. While some children achieved remission, others faced rapid deterioration or were lost to follow-up.
Area of Science:
- Pediatric Rheumatology
- Vasculitis Research
- Clinical Immunology
Background:
- Polyarteritis nodosa (PAN) is a rare systemic vasculitis affecting medium-sized arteries.
- Understanding the clinical spectrum and treatment outcomes in diverse populations is crucial for effective management.
- Limited data exists on childhood PAN specifically from North India.
Purpose of the Study:
- To describe the clinical presentation and spectrum of childhood polyarteritis nodosa (PAN) in North India.
- To highlight any unusual clinical findings associated with PAN in this region.
- To evaluate the treatment outcomes of childhood PAN using prednisolone and cyclophosphamide.
Main Methods:
- A retrospective hospital-based study was conducted.
- The study included eight children diagnosed with polyarteritis nodosa.
- Treatment involved prednisolone and cyclophosphamide, with outcomes assessed over time.
Main Results:
- Six out of eight children achieved remission with the prescribed treatment.
- One child experienced spontaneous remission.
- However, one child deteriorated rapidly despite treatment and died within two weeks; another child died during follow-up, and two were lost to follow-up.
Conclusions:
- The combination of prednisolone and cyclophosphamide demonstrates significant potential in improving outcomes for children with polyarteritis nodosa.
- Despite treatment advancements, challenges remain, including treatment resistance, mortality, and patient follow-up.
- Further research is warranted to optimize management strategies for childhood PAN in North India.